Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

FDA Approves Baxter's Clinolipid Neonatal And Pediatric Indication

Author: Benzinga Newsdesk | May 13, 2024 08:47am
  • Clinolipid provides calories and essential fatty acids for parenteral nutrition
    • Expanded indication demonstrates Baxter's continued commitment to meeting the diverse nutritional needs of patients, from preterm neonates to adults

Posted In: BAX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist